ARTICLE | Company News
Qiagen, Johns Hopkins University deal
February 15, 2010 8:00 AM UTC
Qiagen's DxS subsidiary received an exclusive, worldwide license to the university's phosphoinositide 3-kinase (PI3K) biomarker. The company plans to use the biomarker develop and commercialize compa...